Geneva, June 22 -- International Clinical Trials Registry received information related to the study (NCT07645456) titled 'BOTOX Injection Technique for LUTS Due to BPH' on June 9.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Benha University

Condition: Benign Prostatic Hyperplasia

Intervention: Drug: Botulinum Toxin Type A (BoNT-A)

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: October 1, 2025

Target Sample Size: 60

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07645456

Published by HT Digital Content Services with...